Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v7-FR
Language English French
Date Updated 2020-05-05 2019-10-31
Drug Identification Number 00636908 00636908
Brand name MORPHINE SULFATE INJECTION USP MORPHINE SULFATE INJECTION USP
Common or Proper name MORPHINE SULFATE INJECTION USP MORPHINE SULFATE INJECTION USP
Company Name ICU MEDICAL CANADA INC ICU MEDICAL CANADA INC
Ingredients MORPHINE SULFATE MORPHINE SULFATE
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 10
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-04-01 2019-04-01
Actual start date 2019-04-01 2019-04-01
Estimated end date 2020-06-30 2020-04-01
Actual end date 2020-05-04
Shortage status Resolved Actual shortage
Company comments Product has been discontinued. DIN 00636908 was cancelled 2020-05-04.
Health Canada comments